EU urges member states to boost access to orphan drugs - update
This article was originally published in Scrip
Executive Summary
The European Commissionhas set out a strategy for improving the recognition, diagnosis and treatment of rare diseases. The proposals include speeding up patient access to orphan drugs by better assessing their value for pricing and reimbursement purposes, and encouraging more research into new therapies.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.